Related Experiment Video
Updated: May 4, 2026
10:03
Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
Published on: November 18, 2022
2.1K
Death and dysfunction of transplanted β-cells: lessons learned from type 2 diabetes?
Kathryn J Potter1, Clara Y Westwell-Roper, Agnieszka M Klimek-Abercrombie
1Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Diabetes
|December 21, 2013
Summary
Islet transplantation shows promise for type 1 diabetes, but graft function declines over time. Similarities to type 2 diabetes suggest new therapies targeting beta-cell failure could improve transplant outcomes.
Area of Science:
- Immunology
- Endocrinology
- Transplantation Biology
Background:
- Islet transplantation offers a potential cure for type 1 diabetes by replacing insulin-producing beta-cells.
- Despite improved survival rates due to advancements in procurement and immunosuppression, islet graft function declines progressively, leading to insulin dependence within years.
Purpose of the Study:
- To investigate the mechanisms behind progressive beta-cell dysfunction following islet transplantation.
- To explore potential therapeutic strategies by comparing beta-cell failure in transplantation with type 2 diabetes.
Main Methods:
- Comparative analysis of beta-cell function and pathology in type 1 diabetes islet transplants and type 2 diabetes.
- Examination of markers for impaired insulin secretion, inflammation, oxidative stress, and endoplasmic reticulum stress.
Main Results:
- Progressive loss of beta-cell function in islet transplants mirrors beta-cell failure observed in type 2 diabetes.
- Shared pathologies include impaired glucose-stimulated insulin secretion, inflammation, amyloid formation, and cellular stress.
Conclusions:
- Mechanisms of beta-cell failure in islet transplantation and type 2 diabetes may be common.
- Incretin-based therapies, successful in type 2 diabetes, could potentially augment immunosuppression and improve islet transplant outcomes.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
75
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
01:24Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
01:12Type I Diabetes I: Introduction
45
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45
01:26Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
01:20Pathophysiology of Diabetes
3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
01:22Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K